Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: A prospective, single‐institute study

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|10|1471-1481

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.10, 2014-05, pp. : 1471-1481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil

By  

Oncology, Vol. 89, Iss. 3, 2015-04 ,pp. : 175-186

Karger

Access to resources Recommend Favorite

Fixed-Dose-Rate Gemcitabine in Combination with Oxaliplatin in Patients with Metastatic Pancreatic Cancer Refractory to Standard-Dose-Rate Gemcitabine: A Single-Institute Study

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 333-337

Karger

Access to resources Recommend Favorite

Primitive Neuroectodermal Tumor of the Kidney: A Single-Institute Series of Six Patients from China

By  

Urologia Internationalis, Vol. 90, Iss. 2, 2012-10 ,pp. : 174-178

Karger

Access to resources Recommend Favorite

A Single-Institute Experience with Sorafenib in Untreated and Previously Treated Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 78, Iss. 3-4, 2010-04 ,pp. : 210-212

Karger

Access to resources Recommend Favorite

5-Fluorouracil, Leucovorin and Oxaliplatin plus Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer: A Single-Institute Study

By  

Oncology, Vol. 72, Iss. 1-2, 2007-10 ,pp. : 4-9

Karger

Access to resources Recommend Favorite